Ben Vanneste, Professor of Prostate Cancer Brachytherapy at UZ Gent, shared on LinkedIn:
“Happy to share the publication of our work on developing a National Indication Protocol for Proton Therapy for seminoma testis patients in the Netherlands. The goal is to reduce the risk of subsequent primary cancers, and under this protocol, about 75% of patients qualify for proton therapy.
Further research will help incorporate non-oncological late effects into future selection criteria. Congratulations to Nienke Kuijsters on this great achievement!”
Title: Development of a national indication protocol for proton therapy in patients with seminoma testis to reduce the risk on subsequent primary cancers
Authors: Nienke Kuijsters, Peter Sinnige, Pauline A. Bakker, Shafak Al Uwini, Charlotte L. Brouwer, Tom Budiharto, Rob P. Coppes, Maarten Dirkx, Martine Franckena, Steven Habraken, Marianne A. A. de Jong, Yvonne Klaver, Johannes A. Langendijk, Ada Oele, Erik Schimmel, Ewoud Schuit, Robert Jan Smeenk, Mirko Unipan, Ben Vanneste, Wilma D. Heemsbergen, Liesbeth J. Boersma
Read The Full Article
Other articles about Proton Therapy on OncoDaily.